The monoclonal antibody Itolizumab received authorization to start a phase III clinical trial in Covid-19 patients in the US, Mexico and Brazil
Posted in Inglés

Cuba’s medicine will be tested in the US, Mexico and Brazil

Cuba’s medicine: The monoclonal antibody Itolizumab received authorization to start a phase III clinical trial in Covid-19 patients in the US, Mexico and Brazil

Seguir leyendo